Zhejiang Jiuzhou Pharmaceutical Co., Ltd.SSE: 603456

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by Zhejiang Jiuzhou Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has announced a performance briefing for its annual and quarterly results. The briefing is scheduled for a specific date and will be conducted via video and online interaction. Investors are encouraged to participate and submit questions in advance for discussion during the meeting. The company aims to provide a comprehensive understanding of its performance and strategic plans.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Jiuzhou Pharmaceutical

Later from Zhejiang Jiuzhou Pharmaceutical

All Zhejiang Jiuzhou Pharmaceutical news releases